Justin F. Gainor - Researcher Profile

Publications

3 shown

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer , Karen L. Reckamp , Paul Baas +22 more

Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab tha...

2015 New England Journal of Medicine 8355 citations

Lung cancer

Alesha Thai , Benjamin Solomon , Lecia V. Sequist +2 more

2021 The Lancet 2256 citations

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis , Michael E. Goldberg , Danielle Greenawalt +66 more

Abstract KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups o...

2018 Cancer Discovery 1505 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 12,116
Institution: Massachusetts General Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8697-4081

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.